NCT02462850View on ClinicalTrials.gov

A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
PainNauseaVomiting
Interventions
DRUG

CL-108

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
lead

Charleston Laboratories, Inc

INDUSTRY

NCT02462850 - A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip | Biotech Hunter | Biotech Hunter